1. Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study. Issue 8 (6th June 2022) Authors: Vano, Yann‐Alexandre; Phan, Letuan; Gravis, Gwenaelle; Korakis, Iphigénie; Schlürmann, Friederike; Maillet, Denis; Bennamoun, Mostefa; Houede, Nadine; Topart, Delphine; Borchiellini, Delphine; Barthelemy, Philippe; Ratta, Raffaele; Ryckewaert, Thomas; Hasbini, Ali; Hans, Sophie; Emambux, Sheik; C... Journal: International journal of cancer Issue: Volume 151:Issue 8(2022) Page Start: 1335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. Issue 1 (28th October 2011) Authors: van Eijk-Hustings, Yvonne; van Tubergen, Astrid; Boström, Carina; Braychenko, Elena; Buss, Beate; Felix, José; Firth, Jill; Hammond, Alison; Harston, Benny; Hernandez, Cristina; Huzjak, Masa; Korandová, Jana; Kukkurainen, Marja Leena; Landewé, Robert; Mezieres, Maryse; Milincovic, Marijana; Moret... Journal: Annals of the rheumatic diseases Issue: Volume 71:Issue 1(2012) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial. Issue 5 (May 2022) Authors: Vano, Yann-Alexandre; Elaidi, Réza; Bennamoun, Mostefa; Chevreau, Christine; Borchiellini, Delphine; Pannier, Diane; Maillet, Denis; Gross-Goupil, Marine; Tournigand, Christophe; Laguerre, Brigitte; Barthélémy, Philippe; Coquan, Elodie; Gravis, Gwenaëlle; Houede, Nadine; Cancel, Mathilde; Huillar... Journal: Lancet oncology Issue: Volume 23:Issue 5(2022) Page Start: 612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗